Know Bio, LLC
150 Fayetteville Street
Suite 2300
Raleigh
North Carolina
27601
United States
About Know Bio, LLC
KNOW Bio, LLC was created to develop and optimize the company's proprietary and versatile nitric oxide platform. The technology can be delivered as a drug in a variety of doses and release time frames, which makes the therapeutic areas that will likely be impacted by this platform immense.YEAR FOUNDED:
2015
8 articles about Know Bio, LLC
-
KNOW Bio Announces Breakthrough Nitric Oxide Discovery to Combat COVID-19
9/10/2020
KNOW Bio, LLC has generated the first definitive evidence that nitric oxide (NO) can inhibit viral reproduction of SARS-CoV-2, the human coronavirus that causes COVID-19. Nitric oxide is a molecule pro
-
KNOW Bio Announces Acquisition of Clinical Sensors, Inc.
12/19/2019
Nitric oxide release technology will have broad applications for unmet needs in diabetic health management
-
Vast Therapeutics Receives Qualified Infectious Disease Product Status for BIOC11
10/8/2019
Vast Therapeutics, Inc., a subsidiary of KNOW Bio, LLC, announced that another of its drug candidates, BIOC11, has been designated as a "Qualified Infectious Disease Product" by the U.S. Food and Drug Administration.
-
KNOW Bio Announces Closing of $30 Million in Equity Financing
5/15/2019
Follows $25 Million in Corporate Commitment Last December
-
KNOW Bio Announces Creation of Digestive Health Therapeutics, Inc.
2/26/2019
Company benefits from research with large pharma partner Nitric oxide powder technology will have broad applications for unmet needs in gastrointestinal health
-
Movers and Shakers Oct. 1
10/1/2018
Here's a look at who shook things up in the world of pharma and biotech this week. -
Novan Acquires IP Rights to Treat Viral Malignancies With Nitric Oxide
10/18/2017
Novan completed a transaction with KNOW Bio, LLC granting Novan exclusive worldwide rights for certain oncovirus applications of nitric oxide-based products.
-
Know Bio, LLC Respiratory Has New Name, Novoclem Therapeutics, New Antimicrobial Drug Candidate For Lung, Respiratory Infections
4/11/2017